Tag: Sacubitril/valsartan

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Sacubitril/valsartan

Big pharma catalysts to ring in the new year

Added to Collection on: 2020-12-15 15:56:15

Tags for this article:

Drugs
Monoclonal antibodies
Aducanumab
Biogen
Sacubitril/valsartan
Filgotinib
Eli Lilly
Bristol

Click the tags to see associated articles and topics

View Article Details
Novartis expects sales lift from expanded heart drug approval

Added to Collection on: 2021-02-17 15:45:00

Tags for this article:

Life Sciences
Health sciences
Health care
Combination drugs
Sacubitril/valsartan
Novartis
Pfizer
Ejection fraction
Heart failure
Medication

Click the tags to see associated articles and topics

View Article Details
Big pharma's key catalysts in the second quarter

Added to Collection on: 2021-03-24 13:41:15

Tags for this article:

Drugs
Health sciences
Clinical medicine
Breakthrough therapy
Monoclonal antibodies
Antineoplastic drugs
Bristol-Myers Squibb
Aducanumab
Orphan drugs
Biogen
Sacubitril/valsartan
Pembrolizumab
United States

Click the tags to see associated articles and topics

View Article Details
Congestive Heart Failure Drugs Market Size, Share, Global Analysis, Restrains, Segments ...

Added to Collection on: 2021-04-02 12:11:15

Tags for this article:

Health sciences
Health
Aging-associated diseases
Heart diseases
Organ failure
ACE inhibitors
Heart failure
Novartis
Pharmaceutical industry
Hypertension
Beta blocker
Sacubitril/valsartan

Click the tags to see associated articles and topics

View Article Details
ESC 2024: Study highlights potential for Novartis to differentiate in HF space

Added to Collection on: 2024-09-01 05:58:42

Tags for this article:

Peptide hormones
Angiotensin II receptor antagonists
Heart diseases
Organ failure
Tetrazoles
Sacubitril/valsartan
Heart failure
Valsartan
Natriuretic peptide
ACE inhibitor
Angiotensin II receptor blocker
Atrial natriuretic peptide

Click the tags to see associated articles and topics

View Article Details
Novartis Loses Appeal to Bar Entresto Generic From U.S. Market - BioSpace

Added to Collection on: 2024-12-05 18:59:50

Tags for this article:

Angiotensin II receptor antagonists
Carboxylic acids
Sacubitril/valsartan
Valsartan
Sacubitril
Novartis
FDA citizen petition
Neprilysin
Pharmaceutical industry
Angiotensin II receptor blocker
Heart failure
Entresto

Click the tags to see associated articles and topics

View Article Details
Book a Demo